Gadoteridol Pregnancy and Breastfeeding Warnings
Brand names: Prohance
Medically reviewed by Drugs.com. Last updated on Apr 9, 2024.
Gadoteridol Pregnancy Warnings
Gadoteridol has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of teratogenicity. There are no controlled data in human pregnancy. Gadoteridol is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.
Gadoteridol Breastfeeding Warnings
There are no data on the excretion of gadoteridol into human milk. The manufacturer recommends that caution be used when administering gadoteridol to nursing women.
See also
References for pregnancy information
- (2001) "Product Information. ProHance (gadoteridol)." Bracco Diagnostics Inc
References for breastfeeding information
- (2001) "Product Information. ProHance (gadoteridol)." Bracco Diagnostics Inc
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.